Similar articles

• Management of cranial diabetes insipidus with oral desmopressin (DDAVP).

  Cunnah D, Ross G, Besser GM. Cunnah D, et al. Clin Endocrinol (Oxf). 1986 Mar;24(3):253-7. doi: 10.1111/j.1365-2265.1986.tb03265.x. Clin Endocrinol (Oxf). 1986. PMID: 3708875
• [Effects of DDAVP (1-desamino-8-D-arginine vasopressin) in children with central diabetes insipidus (author's transl)].

  Tomita M, Nakagawa S, Saito N, Sakurada N, Nonoda A. Tomita M, et al. Horumon To Rinsho. 1979 Jun;27(6):681-5. Horumon To Rinsho. 1979. PMID: 466837 Japanese. No abstract available.
• [Treatment of vasopressin-sensitive diabetes insipidus in children with DDAVP].

  Gerards LJ, van Leeuwen EF, Donckerwolcke RA, Kuijten RH. Gerards LJ, et al. Ned Tijdschr Geneeskd. 1975 Aug 16;119(33):1269-72. Ned Tijdschr Geneeskd. 1975. PMID: 1165795 Dutch. No abstract available.
• Vasopressin analog DDAVP in the treatment of diabetes insipidus.

  Lee WP, Lippe BM, La Franchi SH, Kaplan SA. Lee WP, et al. Am J Dis Child. 1976 Feb;130(2):166-9. doi: 10.1001/archpedi.1976.02120030056010. Am J Dis Child. 1976. PMID: 766613 Review.
• [Central diabetes insipidus in the very young child. Treatment with oral desmopressin].

  Fjellestad-Paulsen A, Crosnier H, Czernichow P. Fjellestad-Paulsen A, et al. Arch Fr Pediatr. 1988 Dec;45(10):787-90. Arch Fr Pediatr. 1988. PMID: 3071285 Review. French.